Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid BioTechGrid
  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
  • Home
  • Medical Technology
  • FDA greenlights Abbott’s wearable sensor for capturing diabetic ketoacidosis

FDA greenlights Abbott’s wearable sensor for capturing diabetic ketoacidosis

August 26, 2026Posted inMedical Technology

The FDA has approved Abbott’s first-of-its-kind bio-wearable sensor that can warn diabetics of increased ketones that can lead to diabetic ketoacidosis.

Post navigation

Previous Post
Boston Scientific hit by cyberattack causing ‘disruptions’ to parts of its business
Next Post
New Zika Virus Vaccine Approach Harnesses the Power of T Cells in Mice

Recent Posts

  • Scn1b/Gsdmd knockdown promotes M2-like macrophages, modulating inflammation and fibrosis in rat ARDS
  • Plant Enzymes Enable Efficient Production of N-(Hydroxycinnamoyl)tyramines with In Situ Precipitation
  • FOXP3, Key Regulatory T Cell Activator, Found Across Amphibians
  • MSR Gene Discovery in Four Wheat Species Reveals TaMSRB5 Enhances Copper Tolerance
  • Host selection shapes microbial communities and functions, determining mangrove soil carbon fate

Archives

  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • October 2024
  • September 2024
  • August 2024
  • March 2024
  • January 2024
  • September 2023

Privacy Policy    Terms

Scroll to Top